查詢結果分析
來源資料
相關文獻
- 大腸癌合併肝臟轉移之中醫治療--病例追蹤報告
- 大腸癌手術的現況
- Effect of Vitamin E on Arylamine N-Acetyltransferase Activity in Colon Cancer Tissues
- 糖尿病常見症用藥發徵
- Adenocarcinoma of the Colon Presenting with a Sister Mary Joseph's Nodule (Umbilical Metastasis)--Case Report
- Effect of 5-Fluorouracil on N-Acetyltransferase Activity in Colon Cancer Tissues
- 大腸癌的最近發展
- N-Acetyltransferase Activity and 2-Aminofluorene-DNA Adducts Formation in Human Colon Cancer
- 多發大腸癌之後視力喪失及右肢無力
- 大腸癌之肝臟轉移的手術治療
頁籤選單縮合
題名 | 大腸癌合併肝臟轉移之中醫治療--病例追蹤報告=Treatment of Colorectal Cancer with Liver Metastasis: A Case Report |
---|---|
作者姓名(中文) | 吳修安; 邱榮鵬; 黃伯瑜; 陳建宏; 陳重嘉; 劉佳祐; 陳怡如; 許中華; | 書刊名 | 中醫內科醫學雜誌 |
卷期 | 10:2 2012.12[民101.12] |
頁次 | 頁49-58 |
分類號 | 413.3 |
關鍵詞 | 大腸癌; 中醫藥治療; 藿香正氣散; Colon cancer; Traditional Chinese medicine; TCM; Huoxiangzhengqi; |
語文 | 中文(Chinese) |
中文摘要 | 大腸癌合併肝臟轉移現在已經不再是不治之症了,化療藥物合併標靶藥物治療肝臟轉移的病人使腫瘤先縮小再進行開刀,可切除的大腸癌肝臟轉移的五年存活率為40%。但是仍然有些病人不耐化療藥物的副作用而無法進行完整的手術前化療,導致腫瘤不能開刀,喪失治療的契機。本文是報告一位55歲大腸癌肝臟轉移的病人因不耐西藥化療藥物的副作用尋求中醫治療,在中藥的治療下,完成手術治療的案例。治療原則為扶正祛邪,扶中焦脾胃之氣來緩解化療藥物的副作用,治療的主軸以藿香正氣散、香砂六君子湯扶中焦正氣,祛化療副作用遺毒。 |
英文摘要 | It is no more untreatable disease about colon cancer with liver metastasis, chemotherapy with target therapy before surgery is a standard treatment for those with unresectable liver tumor; it can reduce tumor size and then do surgery with reported 5-years survival rate 40%.(1) Still some patients cannot tolerate the adverse effects of chemotherapy and it lead to lose the opportunity of surgery because of uncompleted chemotherapy. This article is about a 55 years old patient who could not tolerate the adverse effect of chemotherapy before surgery, he finally came for TCM intervention to help him complete the chemotherapy before surgery and then do the surgery. The principle of TCM treatment is to reinforce the healthy qi and eliminate the pathogenic factors, we reinforce the qi of spleen and stomach to ease the adverse effects of chemotherapy, we use Huoxiangzhengqi powder and Xiangsha Liujunzi decoction to treat patient. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。